Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Paul, F."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 223
Tytuł:
Multiscale networks in multiple sclerosis.
Autorzy:
Kennedy KE; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Kerlero de Rosbo N; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.; TomaLab, Institute of Nanotechnology, Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.
Uccelli A; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
Cellerino M; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
Ivaldi F; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
Contini P; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
De Palma R; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
Harbo HF; Department of Neurology, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Berge T; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Oslo Metropolitan University, Oslo, Norway.
Bos SD; Department of Neurology, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Høgestøl EA; Department of Neurology, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Brune-Ingebretsen S; Department of Neurology, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
de Rodez Benavent SA; Department of Neurology, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Paul F; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Brandt AU; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.; Department of Neurology, University of California, Irvine, California, United States of America.
Bäcker-Koduah P; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Behrens J; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Kuchling J; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Asseyer S; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Scheel M; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Chien C; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Zimmermann H; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Motamedi S; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Kauer-Bonin J; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Saez-Rodriguez J; Institute for Computational Biomedicine, University of Heidelberg, Heidelberg, Germany.
Rinas M; Institute for Computational Biomedicine, University of Heidelberg, Heidelberg, Germany.
Alexopoulos LG; ProtATonce Ltd, Athens, Greece.; School of Mechanical Engineering, National Technical University of Athens, Zografou, Greece.
Andorra M; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Llufriu S; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Saiz A; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Blanco Y; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Martinez-Heras E; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Solana E; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Pulido-Valdeolivas I; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Martinez-Lapiscina EH; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Garcia-Ojalvo J; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Villoslada P; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Department of Neurology, Hospital del Mar Research Institute, Barcelona, Spain.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Feb 08; Vol. 20 (2), pp. e1010980. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Multiple Sclerosis*
Humans ; Prospective Studies ; Tomography, Optical Coherence/methods ; Retina ; Brain ; Heat-Shock Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.
Autorzy:
Lin TY; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Chien C; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Kuchling J; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Asseyer S; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Motamedi S; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Bellmann-Strobl J; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Schmitz-Hübsch T; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ruprecht K; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Brandt AU; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Zimmermann HG; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Einstein Center Digital Future, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Jan; Vol. 11 (1), pp. 45-56. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Sclerosis*/pathology
Central Nervous System Diseases*/complications
Humans ; Retinal Ganglion Cells/pathology ; Prospective Studies ; Retrospective Studies ; Atrophy/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
Autorzy:
Wilf-Yarkoni A; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Feldmann K; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Emergency and Acute Medicine, Campus Mitte and Virchow, Charité -Universitätsmedizin Berlin, Berlin, Germany.
Rubarth K; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Charité Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany.
Dorsch EM; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Rust R; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.
Urman I; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hellmann MA; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Friedman Y; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lotan I; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bialer O; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Tel Aviv University, Tel Aviv, Israel.; Neuro-Ophthalmology Unit, Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Buenrostro GS; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Zimmermann HG; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Leutloff C; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Schmitz-Hübsch T; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Asseyer S; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Stiebel-Kalish H; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Tel Aviv University, Tel Aviv, Israel.; Neuro-Ophthalmology Unit, Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 07; Vol. 18 (12), pp. e0288366. Date of Electronic Publication: 2023 Dec 07 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/diagnosis
Optic Neuritis*/complications
Adult ; Humans ; Male ; Infant ; Female ; Methylprednisolone/therapeutic use ; Prednisone/therapeutic use ; Retrospective Studies ; Prospective Studies ; Tomography, Optical Coherence/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
Autorzy:
Chorschew A; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Kesgin F; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bellmann-Strobl J; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Flachenecker P; Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany.
Schiffmann I; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
Rosenthal F; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Althoff P; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Drebinger D; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Department of Physical Medicine and Rehabilitation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Arsenova R; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Department of Pediatrics, St Joseph Krankenhaus Berlin-Tempelhof, Berlin, Germany.
Rasche L; Department of Psychiatry, Schlosspark-Klinik Charlottenburg, Berlin, Germany.
Dorsch EM; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Heesen C; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
Paul F; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Stellmann JP; Aix-Marseille Univ, CNRS, CRMBM, UMR 7339; APHM La Timone, CEMEREM, Marseille, France.; APHM, Hospital de la Timone, CEMEREM, Marseille, France.
Schmitz-Hübsch T; Experimental and Clinical Research Center (ECRC), a cooperation between Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany. .; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. .; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. .; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. .
Pokaż więcej
Źródło:
Health and quality of life outcomes [Health Qual Life Outcomes] 2023 Oct 09; Vol. 21 (1), pp. 110. Date of Electronic Publication: 2023 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*
Humans ; Disability Evaluation ; Quality of Life ; Walking ; Language ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multiple sclerosis and circadian rhythms: Can diet act as a treatment?
Autorzy:
Pivovarova-Ramich O; Research Group Molecular Nutritional Medicine, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.; Department of Endocrinology, Diabetes and Nutrition, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
Zimmermann HG; Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Einstein Center Digital Future, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2023 Apr; Vol. 237 (4), pp. e13939. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Sclerosis*
Neurodegenerative Diseases*
Circadian Clocks*/physiology
Animals ; Humans ; Circadian Rhythm/physiology ; Diet
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis.
Autorzy:
Mohammadi S; School of Medicine, Tehran University of Medical Sciences, Pour Sina St, Keshavarz Blvd, Tehran, 1417613151, Iran.
Gouravani M; School of Medicine, Tehran University of Medical Sciences, Pour Sina St, Keshavarz Blvd, Tehran, 1417613151, Iran.
Salehi MA; School of Medicine, Tehran University of Medical Sciences, Pour Sina St, Keshavarz Blvd, Tehran, 1417613151, Iran. .
Arevalo JF; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, USA.
Galetta SL; Department of Neurology, New York University Langone Medical Center, New York, NY, USA.
Harandi H; School of Medicine, Tehran University of Medical Sciences, Pour Sina St, Keshavarz Blvd, Tehran, 1417613151, Iran.
Frohman EM; Laboratory of Neuroimmunology, Stanford University School of Medicine, Stanford, CA, USA.
Frohman TC; Laboratory of Neuroimmunology, Stanford University School of Medicine, Stanford, CA, USA.
Saidha S; Division of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Sattarnezhad N; Division of Multiple Sclerosis and Neuroimmunology, Department of Neurology, Stanford Multiple Sclerosis Center, Stanford University, Stanford, USA.
Paul F; Department of Neurology, Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, NeuroCure Clinical Research Center, Charité Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 Mar 27; Vol. 20 (1), pp. 85. Date of Electronic Publication: 2023 Mar 27.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Multiple Sclerosis*/diagnostic imaging
Optic Neuritis*
Humans ; Tomography, Optical Coherence/methods ; Retina ; Angiography ; Retinal Vessels/diagnostic imaging ; Fluorescein Angiography/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.
Autorzy:
Sperber PS; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Cardiovascular Disease (DZHK), Berlin, Germany.
Brandt AU; Department of Neurology, University of California, CA, Irvine, USA.
Zimmermann HG; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Bahr LS; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Chien C; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Department of Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Rekers S; Berlin School of Mind and Brain, Humboldt Universität Berlin, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Mähler A; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Böttcher C; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Asseyer S; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Duchow AS; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Bellmann-Strobl J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ruprecht K; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Schmitz-Hübsch T; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany. .; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany. .; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. .; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. .; Experimental and Clinical Research Center, Clinical Neuroimmunology Group, Lindenberger Weg 80, 13125, Berlin, Germany. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2022 Dec 14; Vol. 22 (1), pp. 479. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Multiple Sclerosis*/diagnosis
Neuromyelitis Optica*/diagnosis
Humans ; Aquaporin 4 ; Autoantibodies ; Berlin ; Longitudinal Studies ; Myelin-Oligodendrocyte Glycoprotein ; Observational Studies as Topic ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
Autorzy:
Stiebel-Kalish H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Petach Tikva, Israel.; Division of Neuro-Ophthalmology, Department of Neuro-Ophthalmology, Rabin Medical Center, Beilinson Hospital, 4941492, Petach Tikva, Israel.
Rubarth K; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Institute of Medical Informatics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin, Germany.
Shouchane-Blum K; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Petach Tikva, Israel.
Tiosano A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Petach Tikva, Israel.
Lotan I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Hellmann MA; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Wilf-Yarkoni A; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Bialer O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Petach Tikva, Israel.
Flanagan EP; Departments of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN, USA.
Pittock SJ; Departments of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN, USA.
Bhatti MT; Department of Neurology, Laboratory Medicine and Pathology, Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.; The Permanente Medical Group, Oakland, NC, USA.
Schmitz-Hübsch T; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Asseyer S; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. .
Chen JJ; Departments of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Dec 09; Vol. 12 (1), pp. 21312. Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Optic Neuritis*
Neuromyelitis Optica*
Multiple Sclerosis*
Humans ; Myelin-Oligodendrocyte Glycoprotein ; Retrospective Studies ; Prospective Studies ; Autoantibodies ; Immunoglobulin G ; Aquaporin 4 ; Obesity/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prior optic neuritis detection on peripapillary ring scans using deep learning.
Autorzy:
Motamedi S; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Yadav SK; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Nocturne GmbH, Berlin, Germany.
Kenney RC; Departments of Radiology and Radiological Sciences and Electrical and Computer Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Departments of Neurology, Population Health and Ophthalmology, New York University, New York, New York, USA.
Lin TY; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Kauer-Bonin J; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Nocturne GmbH, Berlin, Germany.
Zimmermann HG; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Galetta SL; Departments of Neurology, Population Health and Ophthalmology, New York University, New York, New York, USA.
Balcer LJ; Departments of Neurology, Population Health and Ophthalmology, New York University, New York, New York, USA.
Paul F; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Brandt AU; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neurology, University of California, Irvine, California, USA.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Nov; Vol. 9 (11), pp. 1682-1691. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Deep Learning*
Optic Neuritis*/diagnostic imaging
Multiple Sclerosis*/diagnostic imaging
Humans ; Tomography, Optical Coherence/methods ; Retina
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.
Autorzy:
Gigengack NK; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Oertel FC; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Motamedi S; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Bereuter C; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Duchow A; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Rust R; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Bellmann-Strobl J; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ruprecht K; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Schmitz-Hübsch T; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Brandt AU; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.; Department of Neurology, University of California, Irvine, CA, USA.
Zimmermann HG; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany. .; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. .; Einstein Center Digital Future, Berlin, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Oct 20; Vol. 12 (1), pp. 17545. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article
MeSH Terms:
Neuromyelitis Optica*
Optic Neuritis*
Multiple Sclerosis*/complications
Multiple Sclerosis*/pathology
Aquaporins*
Humans ; Retrospective Studies ; Tomography, Optical Coherence/methods ; Vision Disorders/complications ; Glycoproteins ; Aquaporin 4
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Autorzy:
Lohmeier J; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte (CCM), Charitéplatz 1, 10117, Berlin, Germany. .
Silva RV; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Einstein Center for Neurosciences Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Lindenberger Weg 80, 13125, Berlin, Germany.
Tietze A; Institute of Neuroradiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte (CCM), Charitéplatz 1, 10117, Berlin, Germany.
Taupitz M; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte (CCM), Charitéplatz 1, 10117, Berlin, Germany.
Kaneko T; Center for the Evolutionary Origins of Human Behavior, Kyoto University, Inuyama, Aichi, 484-8506, Japan.
Prüss H; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte (CCM) and German Center for Neurodegenerative Diseases (DZNE) Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Paul F; NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Lindenberger Weg 80, 13125, Berlin, Germany.
Infante-Duarte C; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Lindenberger Weg 80, 13125, Berlin, Germany.
Hamm B; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte (CCM), Charitéplatz 1, 10117, Berlin, Germany.
Caravan P; A. A. Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging, Massachusetts General Hospital, Harvard Medical School, 149 Thirteenth Street, Suite 2301, Charlestown, MB, 02129, USA.
Makowski MR; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte (CCM), Charitéplatz 1, 10117, Berlin, Germany.; Department of Radiology, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Sep; Vol. 49 (11), pp. 3692-3704. Date of Electronic Publication: 2022 May 04.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalomyelitis, Autoimmune, Experimental*/diagnostic imaging
Encephalomyelitis, Autoimmune, Experimental*/pathology
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/pathology
Animals ; Contrast Media ; Fibrin ; Humans ; Magnetic Resonance Imaging/methods ; Mice
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CD4 T cell subset promotes murine neuroinflammation.
Autorzy:
Benkhoucha M; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Tran NL; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Breville G; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Department of Neurosciences, Division of Neurology, University Hospital of Geneva, Geneva, Switzerland.
Senoner I; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Bradfield PF; MesenFlow Technologies SARL, Chemin des Aulx 14, Geneva, Switzerland.
Papayannopoulou T; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
Merkler D; Division of Clinical Pathology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Korn T; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute for Experimental Neuroimmunology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.
Lalive PH; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. .; Department of Neurosciences, Division of Neurology, University Hospital of Geneva, Geneva, Switzerland. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2022 Apr 29; Vol. 19 (1), pp. 103. Date of Electronic Publication: 2022 Apr 29.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalomyelitis, Autoimmune, Experimental*/pathology
Multiple Sclerosis*/pathology
Animals ; Humans ; Integrin alpha4 ; Mice ; Mice, Inbred C57BL ; Neuroinflammatory Diseases ; Th17 Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and neuroimaging findings in MOGAD-MRI and OCT.
Autorzy:
Bartels F; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin School of Mind and Brain, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and, Humboldt-Universität zu Berlin, Berlin, Germany.
Lu A; Humboldt-Universität zu Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Oertel FC; Humboldt-Universität zu Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Finke C; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin School of Mind and Brain, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and, Humboldt-Universität zu Berlin, Berlin, Germany.
Paul F; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Humboldt-Universität zu Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Chien C; Humboldt-Universität zu Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Department for Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2021 Dec; Vol. 206 (3), pp. 266-281. Date of Electronic Publication: 2021 Jul 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Encephalomyelitis, Acute Disseminated/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Multiple Sclerosis/*pathology
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuroimaging/*methods
Neuromyelitis Optica/*pathology
Aquaporin 4/immunology ; Autoantibodies/immunology ; Brain/diagnostic imaging ; Encephalomyelitis, Acute Disseminated/pathology ; Humans ; Immunoglobulin G/immunology ; Multiple Sclerosis/immunology ; Neuromyelitis Optica/immunology ; Optic Nerve/diagnostic imaging ; Retina/diagnostic imaging ; Spinal Cord/diagnostic imaging ; Tomography, Optical Coherence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.
Autorzy:
Ohle LM; MS Forschungs- und Projektentwicklungs-gGmbH (MS Research and Projectdevelopment gGmbH [MSFP]), Krausenstr 50, 30171, Hannover, Germany.
Ellenberger D; MS Forschungs- und Projektentwicklungs-gGmbH (MS Research and Projectdevelopment gGmbH [MSFP]), Krausenstr 50, 30171, Hannover, Germany.
Flachenecker P; Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany.
Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
Haas J; Deutsche Multiple Sklerose Gesellschaft, Bundesverband e.V. (German Multiple Sclerosis Society, Federal Association), Hannover, Germany.
Hellwig K; Department of Neurology, Katholisches Klinikum, St. Joseph Hospital, Ruhr University Bochum, Bochum, Germany.
Parciak T; Department of Medical Informatics, University Medical Center Göttingen, Göttingen, Germany.
Warnke C; Department of Neurology, Medical Faculty, University Hospital of Cologne, Cologne, Germany.
Paul F; Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Zettl UK; Department of Neurology, Neuroimmunological Section, University Medical Center Rostock, Rostock, Germany.
Stahmann A; MS Forschungs- und Projektentwicklungs-gGmbH (MS Research and Projectdevelopment gGmbH [MSFP]), Krausenstr 50, 30171, Hannover, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jun 25; Vol. 11 (1), pp. 13340. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Sclerosis/*epidemiology
Adult ; Female ; Germany/epidemiology ; Humans ; Male ; Probability ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.
Autorzy:
Ostendorf L; Deutsches Rheuma-Forschungszentrum Berlin, A Leibniz Institute, Berlin, Germany. .
Dittert P; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, A Leibniz Institute, Berlin, Germany.
Biesen R; Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Duchow A; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Stiglbauer V; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Ruprecht K; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine & Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt - Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Bellmann-Strobl J; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Clinical and Experimental Multiple Sclerosis Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine & Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt - Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Seelow D; RG Bioinformatics and Translational Genetics, Berlin Institute of Health (BIH), Berlin, Germany.; Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Stenzel W; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Niesner RA; Deutsches Rheuma-Forschungszentrum Berlin, A Leibniz Institute, Berlin, Germany.; Fachbereich Veterinärmedizin, Institute of Veterinary Physiology, Freie Universität Berlin, Berlin, Germany.
Hauser AE; Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, A Leibniz Institute, Berlin, Germany.
Paul F; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Clinical and Experimental Multiple Sclerosis Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine & Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt - Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Radbruch H; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 May 13; Vol. 11 (1), pp. 10299. Date of Electronic Publication: 2021 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain/*metabolism
Multiple Sclerosis/*metabolism
Sialic Acid Binding Ig-like Lectin 1/*metabolism
Biomarkers/metabolism ; Case-Control Studies ; Flow Cytometry ; Humans ; Interferon-beta/therapeutic use ; Multiple Sclerosis/blood ; Multiple Sclerosis/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sex differences in brain atrophy in multiple sclerosis.
Autorzy:
Voskuhl RR; Department of Neurology, University of California, Los Angeles, 635 Charles E. Young Drive South, Gordon Neuroscience Research Building, Los Angeles, CA, 90095, USA. .
Patel K; Department of Neurology, University of California, Los Angeles, 635 Charles E. Young Drive South, Gordon Neuroscience Research Building, Los Angeles, CA, 90095, USA.
Paul F; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Gold SM; Institute for Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Department of Psychiatry and Medical Department, Division of Psychosomatic Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Scheel M; Institute of Neuroradiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Kuchling J; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Departments of Neurology and Neuropsychiatry, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Cooper G; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Departments of Neurology and Neuropsychiatry, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Einstein Center for Neurosciences, Berlin, Germany.
Asseyer S; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Chien C; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department for Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Brandt AU; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Departments of Neurology and Neuropsychiatry, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Meyer CE; Department of Neurology, University of California, Los Angeles, 635 Charles E. Young Drive South, Gordon Neuroscience Research Building, Los Angeles, CA, 90095, USA.
MacKenzie-Graham A; Department of Neurology, University of California, Los Angeles, 635 Charles E. Young Drive South, Gordon Neuroscience Research Building, Los Angeles, CA, 90095, USA.
Pokaż więcej
Źródło:
Biology of sex differences [Biol Sex Differ] 2020 Aug 28; Vol. 11 (1), pp. 49. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrophy/*etiology
Brain Diseases/*etiology
Multiple Sclerosis/*complications
Adult ; Atrophy/pathology ; Brain Diseases/pathology ; Case-Control Studies ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/pathology ; Sex Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
Autorzy:
Bahr LS; NeuroCure Clinical Research Center and Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität Berlin, Berlin, Germany.
Bock M; Institute of Biochemistry, University Medicine Berlin-Charité, Charitéplatz 1, D-10117, Berlin, Germany.; Department of Medicine B, Ruppin General Hospital, Brandenburg Medical School, 16816, Neuruppin, Germany.; Department of Hand Surgery, Upper Extremity and Foot Surgery, Center for Orthopedics and Trauma Surgery, Hospital Waldfriede, Argentinische Allee 40, 14163, Berlin, Germany.
Liebscher D; Institute of Social Medicine, Epidemiology & Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bellmann-Strobl J; NeuroCure Clinical Research Center and Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität Berlin, Berlin, Germany.; Experimental and Clinical Research Center, a cooperation between Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.
Franz L; NeuroCure Clinical Research Center and Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität Berlin, Berlin, Germany.
Prüß A; Institute of Social Medicine, Epidemiology & Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Schumann D; Institute of Social Medicine, Epidemiology & Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Piper SK; Berlin Institute of Health, Berlin, Germany.; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, D-10117, Berlin, Germany.
Kessler CS; Institute of Social Medicine, Epidemiology & Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin, Berlin, Germany.
Steckhan N; Institute of Social Medicine, Epidemiology & Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Michalsen A; Institute of Social Medicine, Epidemiology & Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin, Berlin, Germany.
Paul F; NeuroCure Clinical Research Center and Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität Berlin, Berlin, Germany.; Experimental and Clinical Research Center, a cooperation between Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.
Mähler A; Experimental and Clinical Research Center, a cooperation between Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany. .; Berlin Institute of Health, Berlin, Germany. .; DZHK (German Centre for Cardiovascular Research), Berlin, Germany. .
Pokaż więcej
Źródło:
Trials [Trials] 2020 Jan 02; Vol. 21 (1), pp. 3. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Fasting*
Quality of Life*
Diet, Ketogenic/*methods
Multiple Sclerosis/*diet therapy
Adolescent ; Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis.
Autorzy:
Böttcher C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. .; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Berlin, Germany. .
Fernández-Zapata C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Berlin, Germany.
Schlickeiser S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.
Kunkel D; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Berlin Institute of Health, Berlin, 10178, Germany.
Schulz AR; German Rheumatism Research Center (DRFZ), Berlin, Germany.
Mei HE; German Rheumatism Research Center (DRFZ), Berlin, Germany.
Weidinger C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Division of Gastroenterology, Infectiology and Rheumatology, Medical Department for Gastroenterology, Berlin, Germany.
Gieß RM; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Berlin, Germany.; NeuroCure Clinical Research Center (NCRC), Berlin, Germany.
Asseyer S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center (NCRC), Berlin, Germany.
Siegmund B; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Division of Gastroenterology, Infectiology and Rheumatology, Medical Department for Gastroenterology, Berlin, Germany.
Paul F; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Berlin, Germany.; NeuroCure Clinical Research Center (NCRC), Berlin, Germany.; Berlin Institute of Health, Berlin, 10178, Germany.; Experimental and Clinical Research Center (ECRC), Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Ruprecht K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Berlin, Germany.
Priller J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. .; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Berlin, Germany. .; Berlin Institute of Health, Berlin, 10178, Germany. .; DZNE, Berlin Germany, University of Edinburgh and UK Dementia Research Institute, Edinburgh, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Dec 19; Vol. 9 (1), pp. 19471. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukocytes, Mononuclear/*immunology
Multiple Sclerosis/*immunology
Adult ; Case-Control Studies ; Female ; Flow Cytometry/methods ; Healthy Volunteers ; Humans ; Leukocytes, Mononuclear/metabolism ; Male ; Mass Spectrometry/methods ; Middle Aged ; Multiple Sclerosis/blood ; Single-Cell Analysis/methods ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
Autorzy:
Olesen MN; Department of Neurology, Slagelse Hospital, Slagelse, Denmark.; Department of Clinical Immunology and Biochemistry, Lillebælt Hospital, Vejle, Denmark.; Institutes of Regional Health Research and Molecular Medicine, University of Southern Denmark, Winsloewsvej 25.2, 5000, Odense C, Denmark.
Soelberg K; Department of Internal Medicine, Slagelse Hospital, Slagelse, Denmark.; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.; Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark.
Debrabant B; Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Nilsson AC; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Lillevang ST; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Grauslund J; Department of Ophthalmology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Brandslund I; Department of Clinical Immunology and Biochemistry, Lillebælt Hospital, Vejle, Denmark.; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Madsen JS; Department of Clinical Immunology and Biochemistry, Lillebælt Hospital, Vejle, Denmark.; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Paul F; Clinical and Experimental Multiple Sclerosis Research Center and NeuroCure Clinical Research Center, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Smith TJ; Departments of Ophthalmology and Visual Sciences and Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
Asgari N; Department of Neurology, Slagelse Hospital, Slagelse, Denmark. .; Institutes of Regional Health Research and Molecular Medicine, University of Southern Denmark, Winsloewsvej 25.2, 5000, Odense C, Denmark. .; Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2019 Mar 11; Vol. 16 (1), pp. 59. Date of Electronic Publication: 2019 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Progression*
Cytokines/*cerebrospinal fluid
Multiple Sclerosis/*cerebrospinal fluid
Multiple Sclerosis/*etiology
Optic Neuritis/*complications
Adolescent ; Adult ; Aged ; Chemokines, CXC/cerebrospinal fluid ; Cohort Studies ; Community Health Planning ; Female ; Humans ; Interleukin-10/cerebrospinal fluid ; Leukocytes/pathology ; Male ; Middle Aged ; Oligoclonal Bands/cerebrospinal fluid ; Predictive Value of Tests ; ROC Curve ; Statistics, Nonparametric ; Tumor Necrosis Factor-alpha/cerebrospinal fluid ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.
Autorzy:
Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany. .
Haas J; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Paul F; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Wildemann B; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2019 Feb 28; Vol. 16 (1), pp. 51. Date of Electronic Publication: 2019 Feb 28.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Diffuse Cerebral Sclerosis of Schilder/*immunology
Multiple Sclerosis/*immunology
Adolescent ; Adult ; Age of Onset ; Aged ; Biomarkers/cerebrospinal fluid ; Child ; Child, Preschool ; Diffuse Cerebral Sclerosis of Schilder/cerebrospinal fluid ; Female ; Humans ; Infant ; Male ; Middle Aged ; Multiple Sclerosis/cerebrospinal fluid ; Oligoclonal Bands/cerebrospinal fluid ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 223

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies